Lisata Therapeutics Inc (LSTA)

[akasidney86]

Can anyone explain this. from F1ash's post?

David J. Mazzo, PhD, Chief Executive Officer of Caladrius. “We are making excellent progress advancing the U.S.-based Phase 2 clinical program of CLBS03 to treat T1D and look to complete enrollment of the first cohort of 18 patients in the coming weeks. This, coupled with our Orphan Drug and Fast Track designations, should make CLBS03 an even more attractive opportunity for a potential partner.”

According to the local news reports posted last month, they had enrolled 19 subjects sometime before June 10th, putting the three month review in the September/October timeframe... which is totally contradicted by Mazzo's statement quoted above, which would put the 3 month check into a December time frame. Big difference. Was the newspaper wrong? They and the other Sanford newsbits that have been posted seem pretty sure about the 19 enrollees. Can anyone contact the company for clarification? I've sent emails, but without a response.